Back

Two-year safety and effectiveness of hybrid ablation versus catheter ablation in patients with non-paroxysmal AF: mid-term results of the CEASE-AF trial

8 April 2024 (10:30 - 11:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: treatment 2 Rhythm Control, Hybrid Therapy EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Maurits Wijffels

St Antonius Hospital, Nieuwegein (Netherlands (The))

8 More presentations in this session

Presentation thumbnail
Hybrid ablation versus repeated catheter ablation in persistent atrial fibrillation: long-term results of the HARTCAP-AF trial.
Ms C. van der Heijden (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes in hybrid versus standalone thoracoscopic ablation in patients with atrial fibrillation: a systematic review and reconstructed individual patient data meta-analysis.
Miss L. Aerts (Maastricht, NL)
Abstract Slides Video
Presentation thumbnail
Intra-procedural three-dimensional rotational angiography in cryoballoon ablation of atrial fibrillation - results from a randomised clinical trial
Doctor I. Prepolec (Zagreb, HR)
Abstract Slides Video
Presentation thumbnail
The hybrid ablation approach to treating long-standing persistent atrial fibrillation: real-world data from a tertiary institution
Doctor V. Lim (Coventry, GB)
Abstract Slides Video
Presentation thumbnail
LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial
Doctor I. Romanazzi (Bari, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: treatment 2

The Event

Event poster

EHRA 2024

8 April 2024 10:30 CET
You may be interested in
thumbnail
Congress Presentation
Three-year safety and effectiveness of Hybrid Ablation versus Catheter Ablation: Final results of the CEASE-AF trial
thumbnail
Congress Presentation
Hybrid AF ablation: EP meets the surgeon
thumbnail
Congress Presentation
Robotic-assisted local epicardial radiofrequency ablation vs. catheter ablation first in patients with persistent and long-standing persistent atrial fibrillation: a multicenter retrospective study.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources